Visits to multiple HIV clinics linked to poorer outcomes

October 9, 2013, University of Pennsylvania School of Medicine

Patients who received care at multiple HIV clinics—as opposed to only one— were less likely to take their medication and had higher HIV viral loads, a new study published in the journal AIDS and Behavior of almost 13,000 HIV patients in Philadelphia from Penn Medicine found. The findings reinforce the notion that continuous care with one provider/clinic is optimal for outcomes and even reducing transmissions, and can help cut down on duplicative HIV services that contribute to higher health care costs.

"It's about retention in care, but also continuity, two related, but distinct processes," said senior author Kathleen A. Brady, MD, an infectious disease physician at Pennsylvania Hospital and Medical Director/Medical Epidemiologist for the Philadelphia Department of Public Health's AIDS Activities Coordinating Office. "This paper helps to describe a group of patients in whom there is duplication of services but who also have worse outcomes. I'm hopeful that by providing this data to HIV clinicians, we can get a better understanding of why patients see multiple providers and make improvements to the system to achieve these goals."

The study was also led by Baligh R. Yehia, MD, MPP, MSHP, an assistant professor in the division of Infectious Diseases at the Perelman School of Medicine at the University of Pennsylvania.

Using data from the City of Philadelphia Department of Public Health, researchers tracked clinic attendance, use of antiretroviral therapy (ART), and HIV viral load suppression between 2008 and 2010 to the 26 Ryan White funded HIV clinics in Philadelphia.

Adjusting for sociodemographic factors, the team found that almost 1,000 of 13,000 patients visited multiple clinics and had poorer outcomes. They were less likely to take ART and had lower viral load suppression rates if they visited multiple clinics for treatment versus the rest who received care at one clinic. Over the study period, 69 percent of patients seeking care at multiple clinics received ART, with 68 percent suppressing HIV viral load. Comparably, 83 percent of patients in care at a single clinic were on ART, with 78 percent achieving viral suppression. What's more, the pattern of multiple clinic use continued year to year for 20 percent of the patients.

Patients who visited multiple clinics were more likely to be younger, black, women, on public insurance or without insurance, and in their first year of care, the researchers note.

The study addresses a larger question of how retention in care is assessed. Most past studies have compared patients consistently in care to those without regular care, but the use of multiple clinics and its impact on outcomes has never been examined. Current measures of retention in care are based solely on primary HIV visits and do not distinguish visits completed at different clinics. So today a patient may have one visit to two separate clinics over the course of a year and be considered "retained" by national standards.

While multiple-clinic visitors represent a minority of patients, this group is of particular interest to HIV providers and officials. For providers, it is critical to document care received at other locations, as this can lead to ART medication errors and unrecognized drug-drug interactions, resulting in harmful side effects and development of drug resistance. On the public health level, receiving care at multiple clinics can lead to duplicative and unnecessary services, resulting in higher .

"In times of diminishing resources, identifying ways to maximize resources and improve HIV outcomes is essential," said Dr. Brady.

For living with HIV, a continuous relationship with a provider has been associated with receiving ART, fewer HIV-related complications and lower risk of HIV transmission to others.

"Next, researchers should focus on better understanding the reasons behind multiple clinics visit, which could run the gamut," said Dr. Yehia. "Difficulty accepting the diagnosis and coping with stigma may play a role. Many people may move onto another clinic because of comorbidity, like hepatitis C and mental health treatments, which may not be offered at all clinics. Patient-provider interactions may also play a role. All of this information will help us better understand patient behaviors, which can help us improve HIV care."

Explore further: Patient satisfaction leads to better HIV care

Related Stories

Patient satisfaction leads to better HIV care

January 30, 2013
In a study of patients at two HIV clinics in the Houston area, researchers at Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center found that those who were satisfied with the care they received ...

Map to avoid detours on road to HIV treatment success: Focus on transitions in care may improve outcomes

March 7, 2013
(Medical Xpress)—Addressing on the challenges that accompany transitions between health care settings could be a key strategy for improving clinical outcomes for people living with HIV, according to researchers from the ...

HIV treatment adherence and outcomes improving among HIV-positive transgender people

May 31, 2013
HIV-positive transgender people are just as likely to stay in care, take their medication and have similar outcomes as other men and women living with the disease, according to new research from the Perelman School of Medicine ...

Hospitalized HIV patients benefit from seeing infectious diseases specialists

October 4, 2013
When patients with HIV are hospitalized for other conditions, such as a heart problem, surgery or complications of diabetes, mistakes are often made involving their complicated anti-retroviral therapy (ART) regimens. But ...

Study details age disparities in HIV continuum of care

June 17, 2013
Age disparities exist in the continuum of care for patients with the human immunodeficiency virus (HIV) with people younger than 45 years less likely to be aware of their infection or to have a suppressed viral load, according ...

More pediatric HIV patients on antiretroviral therapy

August 27, 2013
(HealthDay)—The proportion of perinatally HIV (PHIV)-infected youth on antiretroviral therapy (ART) has increased, leading to decreases in rates of viremia and advanced immunosuppression in recent years, according to a ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.